South Koreas Deputy PM Warns AI Wealth Concentration Risks Worsening Inequality Amid Samsung Labor Strife PDD Holdings Stock Declines as Temu Parents Quarterly Revenue Falls Short of Market Expectations JK Cements 13 Volume Growth Outpaces Industry Amid Cost Pressures CBS and Paramount Retreat from Copyright Enforcement Following Stephen Colberts Viral Parody SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Geopolitical Risk Irans Suspicion of US Ceasefire Terms Adds Uncertainty for Energy Markets LEXX Q1 2026 Earnings Loss Narrower Than Expected Stock Jumps 73 Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase VLYPN Q1 2026 Earnings Preferred Stock EPS Beats Estimates by 507 CRGO Q1 2026 Earnings EPS Misses Estimates by Nearly 70 No Revenue Reported Stock Slides 574 Ready Capital Q1 2026 Earnings Massive EPS Miss Highlights Credit Deterioration Harrow Inc Q1 2026 Earnings Pharmaceutical Firm Misses EPS Estimates by Wide Margin Regional Management Corp RM Edges Higher as Support Holds Steady Bankwell Financial Group BWFG Inches Higher Regional Bank Showcases Measured Recovery Santacruz Silver Mining SCZM Declines 193 as Shares Test Support Near 750 Sweetgreen Inc SG Posts Strong Gains Stock Jumps 89 as Bulls Test Resistance Near 1027 Meta Platforms Edges Higher Amid Consolidation Key Levels in Focus Indias Renewable Energy Sector Faces Grid Integration Headwinds in Q1 2026 Despite 275 GW Capacity Milestone UHAL Q1 2026 Earnings Significant EPS Miss Despite Modest Stock Gain Haymaker Acquisition Corp 4 HYAC Edges Higher as SPAC Holds Above Trust Value Total Return Securities Fund SWZ Holds Steady at 596 Key Levels in Focus NeuroSense Therapeutics NRSN Edges Higher Testing Resistance at 095 Oklo Inc OKLO Surges 338 as Stock Approaches Key Resistance Level EnerSys ENS Declines 25 as Shares Test Key Support Zone Davis Commodities Limited DTCK Holds Steady at 100 Consolidation Phase for Commodity Player Cadrenal Therapeutics CVKD Holds Steady Above Support as Traders Eye Resistance at 545 FibroBiologics FBLG Holds Steady at 105 as Biotech Sector Awaits Catalyst